The role of follow-up after gynaecological cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN67227760

Enrollment

200

Registered

2006-09-29

Start date

2004-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Gynaecological Cancer Gynaecological

Interventions

Rutine follow-up appointments vs system of patent-initiated follow-up

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women who have completed treatment and whose symptoms are controlled.

Exclusion criteria

Exclusion criteria: Patients who still require treatment of some kind.

Design outcomes

Primary

Measure	Time frame
Survival	—

Secondary

Measure	Time frame
Quality of Life, cost effectiveness, rates of surgical and medical intervention in primary and secondary care and patient acceptability	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026